Marketing News

Amorepacific Brings Iope to US Market

This k-beauty skincare brand is online now and heading to shelves inside Sephora this month.

Iope, an Amorepacific brand, is now selling in the US.

With K-beauty‘s trending ingredients still rising in popularity with consumers—and its own sales rising in the Americas—Amorepacific is bringing another high-profile skincare brand to the market. Iope, its clinical-grade skincare range, is now available on Sephora.com in the US, and it will arrive on Sephora shelves by March 13, according to officials speaking on behalf of the brand.

In addition, Iope will also expand its retail presence to Amazon.

Amorepacific in the Americas

Iope joins other Amorepacific brands that have been available in Western markets, including Laneige, Mamonde and CosRx, all of which are sold in the US.

According to 2025 financials released in early February, Amorepacific Group’s “overseas” business saw revenue rise 15% and operating profit jump 102% year-over-year. Growth was reported across all regions. In the Americas specifically, revenue grew 20%. Amorepacific reported strong demand for products such as Laneige lip and skincare products as well as success from the launch of new brands like Aestura and Hanyul.

Amorepacific—No. 15 in Happi’s 2025 International Top 30 List—first debuted in the US in 2003.

Iope in the US

Iope will initially offer nine products in the US, including as XMD Stem III Clinical Recovery Serum, which features “PDRN H.A. Liposome Complex,” a blend of PDRN, micro-molecular hyaluronic acid and allantoin; and Retinol RX 2% Reti-jection Serum, which has a 2% concentration of Retinol RX—Iope’s proprietary retinoid complex.

Prices will range from $6.50 for a single sheet mask to $69 for XMD Stem III Clinical Recovery Cream.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters